Past exam of the medicine course of the University of Oxford / 1865 / Second examination / Diseases of women and children, and surgery / 7 / Solution

The historical prognosis was guarded: malignant disease could return after apparently complete removal, and operative recovery was not equivalent to cure. There is no defensible single percentage for the unspecified case in this question. An answer should explain the seriousness of recurrence, its forms and the evidence needed to estimate it, rather than invent an exact probability.

What counts as return? A new nodule in the scar or nearby skin is a local recurrence; involvement of regional lymph nodes is regional recurrence; disease in distant organs is metastasis. These may represent residual local disease, disease already present but undetected, or later growth of disseminated cells. A grossly clear wound therefore does not prove absence of malignant cells elsewhere. A benign mammary tumour erroneously included with cancers would distort any estimate in the opposite direction.

What an 1865 observer could reasonably say. Visible removal could relieve an ulcerating, painful or bleeding breast lesion, but the subsequent course still had to be observed. The extent of the original growth, fixation to surrounding parts, involvement of axillary nodes, the ability to remove it completely and the interval free from disease all mattered to prognosis. Neither early apparent healing nor a short symptom-free interval established that return could no longer occur.

A contemporary 1863 review makes an especially relevant methodological point: recurrence after operation could not be accurately determined among hospital patients who disappeared from observation unless a rapid return brought them back. Thus a statement about the proportion who returned to the surgeon is not the same as a complete recurrence risk among everyone operated on. This contemporary evidence supports a cautious answer without borrowing a later operation or a modern survival statistic. ^[ref]

Present-day explanation. Breast cancer recurrence risk depends on stage, tumour size and grade, lymph node involvement, completeness of excision and tumour biology. Modern assessment also distinguishes hormone-receptor and other molecular subtypes and takes account of additional treatment. Positive margins, more advanced disease and certain aggressive subtypes increase risk. Consequently a modern estimate requires the actual tumour and treatment information; it cannot be inferred from the bare fact that a breast cancer was removed. ^[ref]

Any numerical claim must specify the population, what event is counted, the treatment, the follow-up period and how patients lost to observation are handled. Death before observed recurrence and the difference between local recurrence and distant disease also affect interpretation. A recurrence percentage is not automatically an operative death rate or a survival rate. The appropriate concise conclusion for this historical question is therefore a substantial concern for return, with prognosis conditioned by extent and completeness of removal, and no guaranteed disease-free interval or universal percentage.